Publisher： Karger
E-ISSN： 1424-0556|1|1|56-65
ISSN： 1422-9528
Source： Heart Drug, Vol.1, Iss.1, 2001-03, pp. : 56-65
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Role of drugs in prevention of coronary restenosis
Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. :
Access to resources
Recommend
Pharmacological Approaches to the Prevention of Restenosis After Coronary Angioplasty
By Hamon M.
Drugs & Aging, Vol. 13, Iss. 4, 1998-10 ,pp. :
Sirolimus feasible for preventing restenosis of coronary artery lesions
Inpharma, Vol. 1, Iss. 1464, 2004-01 ,pp. :
Lower homocysteine levels reduces coronary restenosis rates
Inpharma, Vol. 1, Iss. 1317, 2001-01 ,pp. :
Sirolimus-eluting stent reduces restenosis, coronary events
Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. :